Phase I trial of the addition of oral topotecan to standard 5-day temozolomide for malignant gliomas. Phase II trial of radiation therapy/temozolomide/bevacizumab ...
Interim results of a randomized phase II study of PEGPH20 added to nab-paclitaxel/gemcitabine in patients with stage IV previously untreated pancreatic cancer. This ...
LEIDEN, THE NETHERLANDS, GAINESVILLE, FL, AND NEW YORK, NY, CA / ACCESS Newswire / October 16, 2025 / In a major advancement for Duchenne muscular dystrophy (DMD) research and patient care, a ...
Incurable but not hopeless: How hope shapes patients’ awareness of their advanced cancer prognosis
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback